GlassScriptPhysician profile
D Anderson Millar
NPI 1679727432
$10,521.58
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.52 · 2022: $182 · 2023: $9,986 · 2024: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,548 · Travel and Lodging: $1,132 · Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,548.36 |
| Travel and Lodging | $1,131.65 |
| Food and Beverage | $612.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,892.74 | 2022-2023 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Depuy Synthes Sales INC. | $223.92 | 2022-2024 | Matrixrib |
| Davol INC. | $179.42 | 2024 | Phasix Mesh, Arista Ah Flexitip |
| Kls-Martin L.P. | $66.64 | 2023 | |
| Kerecis Limited | $56.73 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.23 | 2023 | Relistor |
| Integra Lifesciences Corporation | $27.34 | 2021 | |
| Ethicon US, LLC | $23.38 | 2024 | Echelon; Endopath, Harmonic |
| Acacia Pharma INC | $20.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw D Millar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.